VENTANA MEDICAL SYSTEMS  +  ROCHE TISSUE DIAGNOSTICS

1999 - 2010

Over nearly 11 years at Ventana Medical Systems, I was fortunate to launch many innovative, successful medical diagnostic products, build a patent portfolio, contribute to the 2008 acquisition by Roche for $3.4B, and (most importantly) develop a deep appreciation for all the different functions needed to design, develop test, manufacture, service, and market medical devices.  My responsibilities grew quickly, starting as an individual contributor and ultimately running all of product development for a new, flagship product by the time I left.

NOVARTIS COMPANION DIAGNOSTICS

2010 - 2014

I joined Novartis to embrace an opportunity to create a new, fast moving, entrepreneurial business unit within the company.  Working with rockstar talent around me, we developed companion diagnostic systems comprised of custom assays developed on existing or near-market devices. My responsibilities included evaluating those devices, developing custom software, and leading M&A engineering + quality diligence efforts ultimately producing two successful acquisitions: Genoptix in 2011 for $470M and Vivacta in 2012 for $90M.

QUANTERIX

2014 - 2018

While at Quanterix, I was responsible for driving the internal / external development and manufacturing of integrated hardware, optics, software, and image analysis algorithms of an ultra-sensitive immunoassay-driven biomarker detection platform.  During my time there, I successfully lead the stabilization of one platform (HD-1, HD-X) with a partner in Europe while developing another (SR-X) with a completely different partner.  This success supported a wildly successful 2017 IPO, raising $73.3M

  +  MyBIOMETRY  +  OTHER RECENT PROJECTS

Explore below to learn about Prodct LLC (an advisory firm I founded in 2018), myBiometry, and a few of the other entrepreneurial ventures I am currently supporting (or recently supported) directly, as a board member, advisor, or mentor.  Reach out if you'd like to learn more!